Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.85B |
| 2 |
Tesla
TSLA
|
+$1.78B |
| 3 |
Apple
AAPL
|
+$1.57B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.49B |
| 5 |
Mastercard
MA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.3B |
| 2 |
Phillips 66
PSX
|
+$650M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$475M |
| 4 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$432M |
| 5 |
NRG Energy
NRG
|
+$387M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.59% |
| 2 | Financials | 9.21% |
| 3 | Consumer Discretionary | 7.33% |
| 4 | Healthcare | 5.59% |
| 5 | Communication Services | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3701
NewtekOne
NEWT
$380M
| $319K | ﹤0.01% |
26,692
-11,906
| -31% | -$150K |
|
3702
1-800-Flowers.com
FLWS
$265M
| $319K | ﹤0.01% |
54,043
-40,652
| -43% | -$299K |
|
3703
Annexon
ANNX
$865M
| $319K | ﹤0.01% |
165,132
-41,859
| -20% | -$139K |
|
|
ABX
3704
Abacus Global Management
ABX
$834M
| $319K | ﹤0.01% |
+42,531
| New | +$323K |
|
3705
Vishay Precision Group
VPG
$922M
| $318K | ﹤0.01% |
13,209
-6,319
| -32% | -$148K |
|
3706
Byrna Technologies
BYRN
$98M
| $317K | ﹤0.01% |
18,851
-8,545
| -31% | -$221K |
|
3707
Lionsgate Studios
LION
$3.52B
| $317K | ﹤0.01% |
42,420
+32,815
| +342% | +$256K |
|
3708
Latham Group
SWIM
$901M
| $316K | ﹤0.01% |
49,181
-20,296
| -29% | -$137K |
|
3709
Home Bancorp
HBCP
$573M
| $316K | ﹤0.01% |
7,053
-3,542
| -33% | -$166K |
|
|
FBLA
3710
FB Bancorp
FBLA
$253M
| $315K | ﹤0.01% |
+28,000
| New | +$321K |
|
3711
AerSale
ASLE
$273M
| $315K | ﹤0.01% |
42,092
-9,526
| -18% | -$68.1K |
|
|
CWBC
3712
Community West Bancshares
CWBC
$705M
| $314K | ﹤0.01% |
16,997
-8,459
| -33% | -$158K |
|
|
DOO
3713
Bombardier Recreational Products
DOO
$4.74B
| $314K | ﹤0.01% |
9,279
+572
| +7% | +$25.1K |
|
3714
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$6.61B
| $313K | ﹤0.01% |
23,000
| – | – |
|
3715
4D Molecular Therapeutics
FDMT
$603M
| $313K | ﹤0.01% |
97,042
-8,203
| -8% | -$38.6K |
|
3716
Rezolute
RZLT
$454M
| $313K | ﹤0.01% |
108,063
+43,930
| +68% | +$191K |
|
3717
MaxCyte
MXCT
$155M
| $313K | ﹤0.01% |
114,772
-49,260
| -30% | -$194K |
|
3718
Skillsoft
SKIL
$77.2M
| $313K | ﹤0.01% |
16,259
-2,637
| -14% | -$68.7K |
|
3719
Hallador Energy
HNRG
$730M
| $313K | ﹤0.01% |
25,463
-12,603
| -33% | -$142K |
|
3720
Foster
FSTR
$406M
| $310K | ﹤0.01% |
15,776
-4,641
| -23% | -$117K |
|
|
CBLL
3721
CeriBell Inc
CBLL
$877M
| $309K | ﹤0.01% |
16,105
-3,085
| -16% | -$68.6K |
|
3722
Lands' End
LE
$389M
| $308K | ﹤0.01% |
30,276
-4,377
| -13% | -$52.2K |
|
3723
eHealth
EHTH
$39.7M
| $308K | ﹤0.01% |
46,083
+10,730
| +30% | +$97.6K |
|
3724
Cricut
CRCT
$1.23B
| $308K | ﹤0.01% |
59,772
-23,829
| -29% | -$133K |
|
3725
Farmers & Merchants Bancorp
FMAO
$487M
| $306K | ﹤0.01% |
12,780
-6,379
| -33% | -$164K |
|
Similar funds
Barclays's Q1 2025 Portfolio in Review
As of Q1 2025, Barclays held 5,710 positions worth $353B, down 1.2% from $357B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $16.5B of net new capital in Q1 2025, opening 439 new positions and adding to 1,449 existing holdings. Its largest new stake was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.3B trimmed.
- Barclays's largest Q1 2025 buy was JPMorgan BetaBuilders USD High Yield Corporate Bond ETF: 318,453 shares worth $14.7M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $3.85B increase.
- Barclays's biggest Q1 2025 reduction was Honeywell, cutting an estimated $1.3B.
- Barclays fully exited Smartsheet Inc. in Q1 2025, selling an estimated $45.7M.
- Barclays's ten largest holdings make up 37% of its $353B portfolio in Q1 2025.
- Barclays opened 439 new positions and closed 470 in Q1 2025.
- Barclays's portfolio value fell 1.2% quarter-over-quarter to $353B.
Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.